Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau-Durso launched Russia's first production of Danza del Fuego rum

3/12/24 ABRD

Element Group will produce radio modules for base stations

3/12/24 AFKS

RESK reported for 2023 by RAS accounting standards

3/12/24 RZSB

M.video reported for 2023 by RAS

3/12/24 MVID

Yakutskenergo reported for 2023 by RAS

3/12/24 YKEN

Renaissance Insurance management proposed dividends based on 2023 results

3/12/24 RENI

Renaissance Insurance reported for 2023 by IFRS

3/12/24 RENI

M.video reported for 2023 by IFRS

3/12/24 MVID

Sberbank reported for February 2024 by RAS

3/12/24 SBER

VK to launch AI model for training on independent datasets

3/12/24 VKCO